Levels of vaccination coverage among HIV-exposed children in China: a retrospective study

Table 5 Number of vaccines up to date in the study population

Number of vaccines UTD	Total N = 10,033 n (%)	PHIV		HEU		Unknown
Number of vaccines UTD	Total N = 10,033 n (%)	n (%)	OR (95% CI) P-value^a	n (%)	OR (95% CI) P-value^a	n (%)	OR (95% CI) P-value^a
None UTD^b	1462 (14.9)	124 (40.9)	1.00	1164 (12.6)	1.00 –	174 (70.2)	1.00 –
1–4 UTD	5107 (52.1)	151 (49.8)	1.00	4904 (53.0)	3.46 (2.71‒4.43) < 0.001	52 (21.0)	0.25 (0.17‒0.36) < 0.001
All UTD^c	3230 (33.0)	28 (9.3)	1.00	3180 (34.4)	12.10 (7.99‒18.33) < 0.001	22 (8.9)	0.56 (0.31‒1.02) 0.06
Missing or insufficient data	234	3	–	138	–	93	–

CI confidence interval, HEU HIV-exposed uninfected, N number of children, n number of children with the characteristic, OR odds ratio, PHIV perinatally acquired HIV, children perinatally infected with HIV from mothers, UTD up to date, children were classified as up to date if they had received the recommended dose of vaccines before 12 months of age; – means not applicable
^aUnivariate logistic regression;
^bNone UTD: None of the targeted vaccines was UTD at 12 months old;
^cAll vaccines UTD include: BCG, Hep B, MCV, DTP and Polio

ISSN: 2049-9957